NCT00925275View on ClinicalTrials.gov

Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Solid Tumors
Interventions
DRUG

I-131-CLR1404

Single intravenous injection of 10 millicuries of I-131-CLR1404 given on Day 0

Trial Locations (4)

20007

Georgetown University, Lombardi Cancer Center, Washington D.C.

21287

Johns Hopkins University School of Medicine, Baltimore

27710

Duke University Medical Center, Durham

91010

City of Hope, Duarte

Sponsors

Lead Sponsor

Cellectar, Inc
All Listed Sponsors
lead

Cellectar, Inc

INDUSTRY